4D Molecular Therapeutics (FDMT) Other Non-Current Assets (2019 - 2025)
Historic Other Non-Current Assets for 4D Molecular Therapeutics (FDMT) over the last 7 years, with Q3 2025 value amounting to $9.4 million.
- 4D Molecular Therapeutics' Other Non-Current Assets rose 22751.4% to $9.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.4 million, marking a year-over-year increase of 22751.4%. This contributed to the annual value of $4.3 million for FY2024, which is 52295.32% up from last year.
- As of Q3 2025, 4D Molecular Therapeutics' Other Non-Current Assets stood at $9.4 million, which was up 22751.4% from $9.4 million recorded in Q2 2025.
- In the past 5 years, 4D Molecular Therapeutics' Other Non-Current Assets registered a high of $9.4 million during Q2 2025, and its lowest value of $602000.0 during Q1 2021.
- In the last 5 years, 4D Molecular Therapeutics' Other Non-Current Assets had a median value of $1.1 million in 2022 and averaged $2.4 million.
- In the last 5 years, 4D Molecular Therapeutics' Other Non-Current Assets crashed by 3880.95% in 2024 and then skyrocketed by 81348.9% in 2025.
- 4D Molecular Therapeutics' Other Non-Current Assets (Quarter) stood at $602000.0 in 2021, then soared by 79.4% to $1.1 million in 2022, then plummeted by 36.67% to $684000.0 in 2023, then surged by 522.95% to $4.3 million in 2024, then surged by 120.14% to $9.4 million in 2025.
- Its last three reported values are $9.4 million in Q3 2025, $9.4 million for Q2 2025, and $7.0 million during Q1 2025.